A Phase 2, Randomized, Single-Blind, Controlled Trial of Topical Raplixa™ (Fibrin Sealant [Human]) in Intraoperative Surgical Hemostasis in a Pediatric Population
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2017
Price : $35 *
At a glance
- Drugs Fibrinogen/thrombin (Primary) ; Gelatin
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors Mallinckrodt Inc.; ProFibrix; The Medicines Company
- 06 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Jul 2017 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
- 13 Jul 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.